Schedule 13G ownership disclosure

Allogene Therapeutics Inc

Common Stock · CUSIP: 019770106

Event date: 2025-03-31

Filing-level shares
11,450,079
Percent of class
5.3%
  • BlackRock, Inc.

    Shares: 11,450,079 · Class: 5.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001576419-25-000690
Form type
SCHEDULE 13G/A
Filer
Allogene Therapeutics, Inc.
CIK
CIK 1737287
Filed
Apr 17, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub